Medically reviewed by: Kinga Wojtczak, Doctor of Veterinary Medicine, specialist in canine and feline diseases
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Mastocytoma: mast cell tumors. Symptoms and treatment of MCT](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocytoma-guzy-komorek-tucznych-objawy-leczenie-MCT.jpg)
Can a small, innocent-looking skin lump turn out to be a dangerous cancer? Is the vet really right to recommend removing a tiny lesion, and with a margin several times its size? Why does the lump behave so strangely: one time it is small and pale, another time pinkish and much larger? And what kind of name is that anyway: mast cell tumor?
In this article, you will find the most important information about one of the most common skin cancers in animals. I explain which symptoms should worry you, when you should consult a veterinarian, and which breeds are predisposed to developing mastocytoma. You will also learn how the individual tumor grades differ and how to approach the treatment of mast cell tumors sensibly.
- What is mastocytoma?
- Occurrence of MCT
- Why do mast cell tumors develop?
- Mast cell tumors in dogs and cats: symptoms
- Where do the tumors most often develop?
- Diagnosis of mastocytoma
- Mastocytoma prognosis
- Mastocytoma treatment
Table of contents:
What are mast cells?
Mast cells are cells that form part of the makeup of the immune system.
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Mast cells | Source: Wikipedia](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocyty.jpg)
They are present in many tissues, close to blood vessels.
We find them especially in places that separate the external environment from the inside of the body, such as:
- the skin,
- the mucous membrane of the respiratory tract,
- the mucous membrane of the digestive tract,
- the conjunctiva,
- the nasal cavity.
These are the areas where the "sterile" body is most exposed to contact with all kinds of antigens and allergens from the outside. They are also present in connective tissue and around nerves.
Mast cells act as sentinels that alert the body to:
- viral infections,
- bacterial infections,
- the presence of toxins,
- the presence of allergens.
Mast cells take part in very important immune processes, including:
- immediate and delayed hypersensitivity reactions,
- blood pressure regulation,
- connective tissue remodeling,
- wound healing,
- blood clotting,
- angiogenesis.
Why are mast cells important?
In a normally functioning body, when a threat appears, the job of mast cells is to make a lot of "noise" and call in reinforcements to the site of the intrusion as quickly as possible.
To perform their functions properly, they are packed with cytoplasmic granules that contain a large number of bioactive substances, including:
- heparin,
- histamine,
- hyaluronic acid,
- serotonin, and many others.
What happens when a foreign agent appears within the mast cells' range of action? They degranulate, which means they rapidly release these pro-inflammatory substances, and one of the signals for this is the binding of an antigen to an antibody of the IgE class.
The "noise" consists of an intense local (sometimes also systemic) hypersensitivity reaction caused by the released substances, which shows as:
- dilation of blood vessels,
- tissue swelling,
- an influx of granulocytes.
We simply call this inflammation. Under normal conditions, this reaction is needed to mobilize the body's defenses quickly. Sometimes, however, for reasons that are not fully understood, mast cells undergo neoplastic transformation. You now know what mast cells are, but where do these tumors come from? You will find out later in this article.
What is mastocytoma?
Mastocytoma is an uncontrolled, neoplastic growth of mast cells, most often taking the form of a skin (cutaneous) or subcutaneous tumor.
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy What is mastocytoma?](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/co-to-jest-mastocytoma.jpg)
Because of where mast cells are located, the proliferation of neoplastic mast cells can begin anywhere. We therefore distinguish the following forms of the cancer:
| Cutaneous | Mast cell tumor (MCT)—when the neoplastic process affects the skin and/or subcutaneous tissue. |
| Visceral | Affects internal organs—the spleen, liver, digestive tract and mucous membranes. It is much less common. |
| Disseminated mast cell tumor | Cases of disseminated mast cell tumor (regardless of where the cancer originated: the skin or subcutaneous tissue, internal organs, bone marrow), sometimes taking a leukemic form. And a word of caution here: in mast cell leukemia, mast cells are present in the peripheral blood. |
| Non-neoplastic proliferation | Most often within the dermis (mastocytosis). |
The naming of proliferative processes involving mast cells causes some confusion. Veterinary medicine describes 2 types of such lesions:
| Reactive proliferation | In this process, mast cells proliferate in a non-neoplastic way under the influence of some factor (known or unknown). This process is called mastocytosis (Latin: mastocytosis). |
| Neoplastic proliferation | These are typical neoplastic lesions, regardless of their clinical course, and they are called mastocytoma (Latin: mastocytoma). |
The difficulty in interpretation comes from the fact that the literature often uses the term mastocytoma for multifocal neoplastic processes with a malignant course, which are not uncommonly accompanied by altered mast cells in the peripheral blood (leukemia, mastocytosis leucaemica). To emphasize the neoplastic type of growth, it must be called malignant mastocytosis (mastocytosis malignant).
Yes, this cancer can be very dangerous… Later in this article, you will learn whether your pet is in a risk group and when it may develop this disease.
Occurrence of MCT
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Mastocytoma in a dog](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocytoma-u-psa.jpg)
MCT in dogs
Cutaneous mastocytoma is the most common skin tumor in dogs. Of all tumorous lesions, about 25% are mast cell tumors, and about half of these are malignant. Mast cell tumors account for 16–21% of all skin cancers in dogs.
MCT in cats
In cats, the figures are somewhat lower: 1–9% of all neoplastic lesions in this species and 2–7.6% of all skin cancers. Mastocytoma in cats is usually benign, because local or distant metastases are rather rare. Recurrence after surgical removal of the tumor is found in only 0–4% of cases.
Age
Mastocytoma in dogs can occur at any age. It is diagnosed in animals from 4 months to 18 years old, but it most often affects older dogs, 8–9 years old. Mastocytoma in cats can also occur at any age; it usually appears in 10-year-old animals, but it has also been found in 6-week-old kittens.
Which dog breeds are at risk of MCT?
Although the disease has most often been described in mixed-breed dogs, these tumors occur more often in dog breeds such as:
- Boxer, Boston Terrier, Bull Terrier (the 3B breeds; according to some, the letter B often also stands for Benign),
- Fox Terrier,
- Pug,
- Labrador,
- beagles,
- Golden Retriever.
Fortunately, in Boxers and Pugs , and probably in Golden Retrievers, mastocytomas are in most cases well differentiated, have a mild clinical course and usually carry a favorable prognosis. Young Shar-Pei dogs are predisposed to MCT, and their tumors are often poorly differentiated and high grade, and therefore, unfortunately, more aggressive.
On the other hand, some studies have recorded a lower risk of the tumor in:
- Shih Tzus,
- Maltese,
- Yorkshire Terriers,
- Chihuahua,
- Dachshunds,
- Miniature Poodles.
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Tumor in a Yorkie](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/nowotwor-u-yorka.jpg)
In the same study, large-breed dogs had a higher risk of the disease than small-breed dogs:
2 times higher in large dogs up to 36 kg, and 5 times higher in dogs classed as giant, over 36 kg. In cats, Siamese cats are at higher risk, but breed predispositions are not as pronounced as in dogs.
Location of lesions
Mast cell tumors in certain locations are thought to be of higher grade and more aggressive, and therefore to have a worse prognosis.
These locations include:
- the perianal area,
- the perineal area,
- the inguinal area,
- the oral mucosa,
- the lips,
- the subcutaneous tissue (compared with lesions located in the dermis).
Tumors in the subcutaneous tissue are most often intermediate- and high-grade lesions. Conjunctival mastocytomas are usually cancers of intermediate grade (grade II), less often of low grade (grade I), and least often lesions of the highest grade (grade III). They are, however, a challenge for veterinarians because they are difficult to remove completely.
Other risk factors
Heredity can certainly be counted among the other risk factors. In both dogs and cats, viral infections have also been considered as a possible etiological factor of mastocytoma, but this could not be proven. Virus-like particles were even observed in samples taken from affected cats, but it was not possible to transmit the infection or to induce the cancer in laboratory animals.
No association was found between infection with feline leukemia virus (FeLV), feline immunodeficiency virus (FIV) or feline infectious peritonitis virus (FIP) and the development of these tumors. In dogs, in turn, no virions were observed in mastocytoma cells, but in very young puppies or puppies with a compromised immune system it was possible to induce cancer.
The risk of mastocytoma is also higher at sites of:
- previous injuries,
- chronic inflammation,
- burns,
- exposure to irritants.
What is mastocytosis?
In dogs and cats, besides mast cell cancers, there are also mastocytoses (non-neoplastic proliferations).
Depending on the location and severity of the process, 2 forms of mastocytosis are distinguished:
- cutaneous mastocytosis,
- systemic mastocytosis.
In cutaneous mastocytosis, the lesions may regress spontaneously within several months to a year or more. In Sphynx and Devon Rex cats, there have been cases of chronic urticaria pigmentosa (a familial predisposition to it has been found in Sphynx cats). The cause of the disease in cats is unknown; it results from a disorder of mast cell proliferation.
It appears in very young kittens as itchy, red-brown spots and papules all over the body. The second form of mastocytosis, the systemic form, should be included in the differential diagnosis when mast cell tumors become generalized.
Why do mast cell tumors develop?
The causes of mast cell tumors are mostly unknown. They have been linked to the skin inflammation and viral infections mentioned earlier. Currently, mutations in the c-kit receptor gene are being considered. This mutation causes neoplastic transformation of the cells, which results in constant stimulation of their proliferation. Such a mutation was detected in 50% of the analyzed cases of mast cell tumors in dogs, but it has not been described in cats. So far, it is not known whether these mutations cause the tumors to develop or are just another element of the process of tumor formation. The c-kit mutation is found in about 30% of dogs with grade III and IV mast cell cancer. There is no breed predilection.
I know this is not an easy topic, but if you read on, you will learn what the symptoms of mastocytoma are and how you can recognize it in your pet.
Mast cell tumors in dogs and cats: symptoms
Cutaneous mastocytoma
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Cutaneous mastocytoma in a dog: photo of a tumor on the paw](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocytoma-guz-na-lapie-psa.jpg)
In dogs, the main finding is usually a shiny lump raised above the surface of the skin. This is usually the first (sometimes the only) reason for a visit to the veterinarian.
The appearance and behavior of the skin lesion depend largely on its degree of differentiation:
- well-differentiated mastocytomas most often take the form of cutaneous or subcutaneous nodules or masses 1–4 cm in diameter. They are well demarcated from the surrounding tissues and grow fairly slowly.
- poorly differentiated lesions take the form of diffuse swellings of the skin with poorly defined borders and a fairly soft consistency. These tumors grow quickly, can reach a large size and may ulcerate.
What makes cutaneous mastocytoma very hard to recognize is that a mast cell tumor can resemble any other (even harmless) tumor of the skin. Some of them may not change in size for months or even years before they start to spread quickly, while others are aggressive from the very beginning. There are lesions whose surface ulcerates, and there are also ones that take the form of small, single or multiple, raised, reddened and hairless nodules.
Pet owners often say that while petting their pet every day, they felt a lump under the skin (of varying consistency: some say it feels swollen, while others say it is hard). The fact is that MCTs most often arise in the dermis and extend into the subcutaneous tissue and muscle. Involvement of the surrounding tissues is most common with fast-growing tumors.
An important diagnostic sign is the presence of the so-called Darier's sign. When the tumor is handled during palpation or examination, the mast cells degranulate and release biologically active substances. The result is reddening and swelling of the skin and, sometimes, streak-like skin lesions. When asked about the history, owners say that when they stroke the dog in that spot, or even when the dog licks it, the lump changes its appearance very quickly and becomes shiny, and after a while, "fortunately", it shrinks.
Cutaneous mastocytoma in cats takes the form of round, firm papules or nodules from a few millimeters to 2 cm in diameter, most often hairless. They arise in the dermis and spread to the subcutaneous tissue, sometimes infiltrating the epidermis. They are well demarcated from the surrounding tissues and usually unencapsulated.
Visceral mastocytoma
The most common signs of the visceral form of MCT (this term refers to disseminated or systemic mastocytosis) are:
- generalized lymph node enlargement,
- liver enlargement,
- spleen enlargement.
In these animals, we usually see:
- lethargy,
- weight loss,
- decreased appetite,
- vomiting,
- diarrhea.
In patients with the visceral form of the disease, neoplastic mast cells are often found in the bone marrow and bloodstream, as well as in pleural and peritoneal effusion (if present). Primary gastrointestinal MCT has also been described in dogs, in the form of tumors spread along the entire length of the digestive tract.
Here we often see:
- vomiting,
- diarrhea,
- blood in the stool.
Unfortunately, this form of cancer in dogs has a very poor prognosis.
Where do the tumors most often develop?
Tumors in dogs are most often located:
- in the groin area,
- on the trunk,
- on the limbs,
- in the genital and perineal area,
- on the head,
- on the neck.
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Mastocytoma in a dog: photo of a lesion on the inner thigh](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocytoma-u-psa-wewnetrzna-strona-uda.jpg)
Although less often, mastocytomas have also been described:
- at the base of a claw,
- in the oral and nasal cavities,
- in the larynx,
- in the trachea,
- in the area of the prepuce,
- in the area of the vulva,
- in the perianal area.
Occasionally, tumors also develop in places such as:
- the conjunctiva,
- the salivary glands,
- the digestive tract,
- the ureters,
- the spinal cord.
In cats, they occur mainly on the head and neck (60% of cases).
Complications of the cancer
Unfortunately, the presence of the primary tumor or secondary foci is not the end of our patients' health problems… They also relatively often show other clinical signs, which are the result of the action of bioactive substances released from mast cells. Complications may also be caused by metastases in internal organs.
These are the so-called paraneoplastic syndromes, and the most common ones are:
| Gastric and intestinal ulceration | Most often in the pyloric region of the stomach and the proximal duodenum. The ulcers most likely occur because mast cells release histamine, which stimulates the parietal cells of the stomach to secrete more hydrochloric acid. The main signs are abdominal pain, decreased appetite or loss of appetite, vomiting (often with blood) and tarry stools (melena). In rare cases, it ultimately leads to perforation of the wall of the digestive tract. |
| Blood clotting disorders | Handling the tumor, and the resulting mast cell degranulation with release of large amounts of heparin, can lead to local bleeding that is hard to stop, which is very dangerous, especially during surgery (interestingly, bleeding can occur even if the blood clotting parameters were normal before surgery). |
| Drop in blood pressure | During surgery it can lead to a life-threatening situation. |
| Delayed wound healing at the site where the tumor was removed | The "credit" here goes to the local action of proteolytic enzymes and vasoactive amines released by the tumor. |
Mastocytoma metastases
The true metastatic potential of mast cell cancers in dogs is not yet fully understood.
However, the histological grade can be used to predict metastatic behavior:
- as a rule, the metastatic potential of well-differentiated tumors is low (below 10%),
- for intermediate-grade cancers, it is low or moderate,
- undifferentiated cancers metastasize at a rate of 55% to as much as 96%.
Metastases, if they occur, appear mainly:
- in the nearby lymph nodes,
- in the spleen and liver,
- in other abdominal organs.
They appear exceptionally rarely in the lungs. Cytopathology studies have shown that lymph node metastases are seen in 36.2% of dogs with mastocytoma. They most often affect patients with tumors of the highest grade (although they can also accompany low-grade cancers). In the systemic form, neoplastic mast cells may be seen in the bone marrow and in the blood.
Bone marrow involvement is seen in over 50% of cases of anaplastic visceral MCT.
Diagnosis of mastocytoma
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Tumor cells: cytology](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/komorki-nowotworowe-cytologia.jpg)
Biopsy
Diagnosing MCT is usually not complicated and is based on a fine-needle aspiration biopsy (FNA) or a fine-needle non-aspiration biopsy (FNNA). As soon as the owner mentions that the lump appeared recently, is shiny, changes in size (sometimes getting bigger, sometimes smaller) and is sometimes reddened, alarm bells should go off and we should include mastocytoma in the differential diagnosis.
MCT may be suspected from the appearance of the lesion, the dog's breed predisposition and the presence of Darier's sign. Examination of material obtained by fine-needle aspiration biopsy is a quick, sensitive and inexpensive method. It is usually enough to make a diagnosis, but it does not allow a prognosis of the further course of the disease. However, a final diagnosis is possible only after at least a cytopathological examination of the biopsy sample, and ideally a histopathological examination of material taken during an incisional biopsy or surgical removal of the lesion.
Histopathology
Histopathological examination of material obtained by incisional biopsy makes it possible to determine the tumor grade. This allows the surgery to be planned precisely (determining the width of the surgical margins), a prognosis for the future to be given and the appropriate treatment to be chosen.
Surgical biopsy
A surgical biopsy with simultaneous definitive and complete removal of the lesion. Its drawback is that it requires wide surgical margins when the material is collected (if it is the first diagnostic technique used).
Staging the cancer
All right. We have a confirmed mast cell tumor. What next? What is the prognosis? How is the treatment method chosen? What is our patient's survival? To answer these questions, it is extremely important to establish the stage of the disease process.
This is the purpose of the World Health Organization (WHO) classification system, which defines the stage of disease for dogs with the cutaneous form of MCT:
| Clinical stage | Type of tumor |
|---|---|
| I | A single tumor confined to the skin, without regional lymph node involvement A. (without systemic signs) B. (with systemic signs) |
| II | A single tumor confined to the skin, with regional lymph node involvement A. (without systemic signs) B. (with systemic signs) |
| III | Multiple skin tumors or large infiltrating tumors, with or without regional lymph node involvement A. (without systemic signs) B. (with systemic signs) |
| IV | Any tumor with distant metastases, or recurrence with metastases (including bone marrow or peripheral blood involvement, i.e., leukemia) |
What the outlook for our friend will be, what kind of therapy the oncologist will choose, what accompanying signs (roughly) we need to be prepared for and what the average survival of a patient with MCT will be all depend on which (unenviable) place in the table the tumor takes. To put it in the right place, however, a number of tests have to be performed, and they are often quite invasive.
| Thorough physical examination, complete blood count and blood chemistry, urinalysis | Performed to assess the animal's general condition, organ function and any infections. |
| Blood smear evaluation | Should answer the question of whether circulating mast cells are present, and in what numbers. |
| Abdominal X-rays | Assessment of the internal organs (with particular attention to the liver and spleen). |
| Chest X-rays | Chest X-rays with assessment of the lungs. |
| Abdominal ultrasound | Again with careful assessment of the echogenicity of the liver and spleen; assessment of the lymph nodes and of any metastatic tumors. |
| Cytology of the bone marrow and regional lymph nodes | When indicated, cytology of the bone marrow and regional lymph nodes is performed. A fine-needle aspiration biopsy of the nearby lymph nodes should be performed if they are enlarged. However, a suspicion based on cytology should be confirmed by histopathology (in about 25% of healthy dogs, a small number of mast cells can be found in lymph node samples). Metastases to the nearby lymph nodes are seen in 3.2% of patients with mastocytoma. They occur most often in patients with tumors of the highest grade (but they can also accompany low-grade cancers). Bone marrow biopsy: finding more than 10 mast cells per 1000 nucleated cells indicates development of the disease. However, this test should be interpreted very cautiously. |
| Cytology or histopathology of a liver/spleen biopsy sample | Enlargement of these organs on X-ray or ultrasound may indicate that the cancer is spreading, but this should always be confirmed by testing. |
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy X-ray of a Golden Retriever](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/Zdjecie-rentgenowskie-golden-retriever.jpg)
Mastocytoma prognosis
The information gathered from the history, the physical examination and all the other additional tests becomes, in a sense, the building blocks that, put together skillfully, make it possible to build an accurate and precise diagnosis. At the same time, it forms a solid prognostic foundation for the patient's future.
Remember, however, that the whole process of establishing a prognosis for your pet is complex and depends on many factors.
Tumor grade
The grade is determined during histopathological examination. It is considered the most important prognostic factor in dogs with the cutaneous form of MCT. The most commonly used grading system is the Patnaik system for mastocytoma (a 3-tier classification).
It distinguishes 3 histological grades:
| Grade I | Made up of well-differentiated cells (mastocytoma G1). |
| Grade II | Made up of intermediately differentiated cells (mastocytoma G2). |
| Grade III | Made up of poorly differentiated cells (mastocytoma G3). |
Grade I mastocytomas most often occur in the dermis and less often reach the subcutaneous tissue. They are well demarcated from the surrounding tissues. The tumor cells of grade II mastocytoma often infiltrate the subcutaneous tissue as well as the neighboring tissues. Grade III mastocytomas reach the largest size and infiltrate the subcutaneous tissue and the epidermis, and their surface often ulcerates.
Because pathologists disagree in grading mast cell tumors, a new two-tier grading system by Kiupel has been proposed. It divides mastocytomas into:
- low-grade,
- high-grade (histologically).
For example:
Grade III mastocytoma is often associated with the tumor being impossible to remove completely by surgery and with the appearance of metastases. In such dogs, remission time is much shorter, and the tumor is the cause of death almost 4 times as often as with lower-grade cancers.
The average survival time for dogs with a low-grade tumor is over 2 years, while for high-grade tumors it is under 4 months. Generally speaking, it can be said that:
| Grade I MCT | These lesions are confined to the skin, and distant metastases are rare. Death due to recurrence or distant metastases occurs in about 10% of dogs. |
| Grade II MCT | These are usually also lesions confined to the skin, but they are more aggressive. Metastases to the nearby lymph nodes and distant sites are found in 45% of cases. |
| Grade III MCT | Death due to recurrence or the presence of secondary foci (including in internal organs) is found in 85% of cases. |
In cats, the following histopathological types of mast cell tumors are distinguished:
- Mastocytic: * Well-differentiated. * Poorly differentiated (anaplastic).
- Histiocytic.
Most mastocytomas in cats are mastocytic mastocytomas; histiocytic mastocytomas are seen less often. The link between the degree of differentiation of the tumor and its behavior is not as clear as in dogs. Poorly differentiated mastocytic mastocytomas, however, tend to recur after surgery and to metastasize to the lymph nodes and internal organs.
Growth rate
Tumors that grow faster than 1 cm per week have a worse prognosis.
Surgical margins
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Surgery: tumor resection in a dog](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/zabieg-chirurgiczny-resekcja-guza-u-psa.jpg)
Complete excision of the cancer during surgery is an important prognostic factor and also helps determine whether adjuvant therapy is needed. Unfortunately, it often happens that the margins the surgeon allowed for do not match those assessed by the pathologist; in short, the tumor was not removed completely. The aim should always be clean surgical margins, if possible, of course.
The following guidelines are currently accepted for the histological assessment of surgical margins:
| Complete resection | No tumor cells within 1 mm of the edge of the surgical margin. |
| Complete but close resection | Mast cells within 1 mm of the edge of the surgical margin. |
| Incomplete resection | Mast cells at the edge of the surgical margin. |
In a nutshell, for non-metastatic grade I and II tumors with clean margins, further treatment is often not needed, and the patient can simply be monitored regularly.
Location of the mastocytoma
It has been suggested that mast cell cancers on the limbs have a better prognosis than those on the trunk. Tumors in the groin and perineal area, on the other hand, usually have a poor prognosis: they recur more often. Cancers located on the muzzle are of high grade (grade III) and have a stronger tendency to metastasize to the nearby lymph nodes. If internal organs or the bone marrow are involved, this usually means a poor prognosis.
Number of tumors
Multiple tumors indicate an advanced stage of the disease. Sometimes, however, their presence does not necessarily mean a worse prognosis. In cats with multiple mast cell tumors, the prognosis should be guarded or unfavorable because of the risk of metastases or of new tumors developing in the skin.
Stage of the disease
The presence of metastases means a short survival time. Enlargement of the lymph nodes, spleen or liver, or the presence of satellite nodules, results in a worse prognosis.
Similarly, the co-occurrence of paraneoplastic syndromes significantly worsens the prognosis for our patient. These are:
- loss of appetite,
- vomiting,
- diarrhea,
- tarry stools.
Cell proliferation markers
In cases where the prognosis and treatment are hard to determine, tumor markers can be measured:
| Argyrophilic nucleolar organizer regions (AgNOR) | Their average number per cell correlates well with the tumor grade. A high number of AgNORs in the nucleus of a tumor cell in dogs means more aggressive cancer behavior than a low number of AgNORs. |
| Ki-67 | The average number of Ki-67-positive cells is significantly higher in aggressive high-grade mastocytomas. There is also a strong correlation with survival time after surgery. |
| Mitotic index | More than 10 mitotic figures per 10 fields of view (high-power fields) means a poor prognosis. |
C-kit mutation
It is found in about 30% of dogs with grade III and IV MCT. It shows no breed predisposition. The presence or absence of negative prognostic factors, as well as the clinical presentation, are key to deciding on therapy and establishing the prognosis. This must be kept in mind when planning time-consuming and costly therapy. Later in this article, you will learn how this cancer is treated.
Mastocytoma treatment
How is mastocytoma treated? The basic element of treating mast cell tumors is complete surgical resection of the tumor, sometimes supported by additional methods such as chemotherapy or radiation therapy.
The choice of treatment method depends on:
- the histopathological grade of the tumor,
- the location of the lesion,
- how advanced the disease process is,
- the availability of treatment methods,
- the owner's commitment and financial means.
Surgery
![Mast Cell Tumors in Dogs, Cats: Symptoms, Treatment [Krystyna Skiersinis, DVM] - Co w Sierści Piszczy Mastocytoma in a dog: surgery](https://cowsierscipiszczy.pl/wp-content/uploads/2016/10/mastocytoma-u-psa-zabieg-chirurgiczny.jpg)
The first surgery offers the best chance of a cure, because the fasciae are still intact, there is no scar tissue at the incision site, and the tumor is clearly visible. In dogs with well-differentiated and intermediately differentiated mastocytomas (grade I and II) confined to the skin and subcutaneous tissue (and removable!), the treatment of choice is surgery. The established practice is to remove mast cell tumors with a 3 cm margin on every side of the lesion and to a depth of one cutaneous muscle (if present) and the fascia beneath it, or, where there is none, the superficial muscle layer.
The requirements have now been relaxed somewhat, and in such cases a lateral margin of 2 cm and removal of 1 fascial layer below the tumor are considered sufficient. Why such a safety margin? The aim is to have histopathology confirm that there are no tumor cells at the surgical cut line. In that case, no additional treatment is needed, and about 98% of dogs have a good prognosis.
If, however, tumor cells are present at the cut line, a wider excision is recommended (if possible), and the next surgery should include the area of the first excision plus a margin of 2–3 cm and deeper tissues.
For intermediately or poorly differentiated tumors located on the limbs, or tumors that cannot be removed completely, there are 3 options:
- Radical surgery, e.g. amputation of the affected limb.
- Radiation therapy
- Excision of the lesion combined with radiation therapy.
If the tumor cannot be removed because of its location, or if it is a G3 mastocytoma, adjuvant therapy is indicated. Surgery here is only palliative and may be combined with radiation therapy and chemotherapy. A common complication after surgery is delayed wound healing, which is why the stitches are often removed not after 10 days but after as long as 3 weeks.
Radiation therapy
Neoplastic mast cells are fairly sensitive to ionizing radiation, even at moderate doses. Radiation therapy is especially indicated for incompletely removed tumors. It can also relieve the signs of systemic disease. When the tumor is poorly differentiated or metastases are confirmed, palliative radiation therapy can improve quality of life by shrinking particularly large or irritating tumors and by stopping bleeding.
However, with massive tumors, radiation can cause serious systemic effects. To put it simply, radiation therapy can relieve the signs, but it does not significantly prolong survival time.
Chemotherapy
Chemotherapy complements surgery and radiation therapy (although, for various reasons, it is sometimes used as the only method). Drugs such as vinblastine and lomustine have been shown to have some efficacy against mast cell tumors in dogs. Other chemotherapy drugs currently being studied for efficacy in dogs are vinorelbine and the new drug paclitaxel (Paclical VET).
Chemotherapy is intended mainly for patients:
- with metastases,
- with G3 mastocytoma,
- when the tumor has been removed incompletely,
- when surgery is not possible.
Sometimes it is started as the first method, before surgery and/or radiation therapy, or as monotherapy (some owners decide against other forms of treatment).
Corticosteroids
Used mainly in palliative therapy.
The treatment protocol and choice of drugs are determined individually by the veterinarian. For example, it may look like this:
- Prednisolone at a dose of 2 mg/kg/day for 2 weeks,
- then 1 mg/day for the next 2 weeks,
- then 1 mg/kg/day every other day.
Electrochemotherapy
Electrochemotherapy is the local administration of a chemotherapy drug combined with exposing the tumor to an electric current, which helps the drug penetrate the tumor tissue better. Cisplatin is given in 2 sessions 7 days apart. ECT is usually well tolerated by patients. Sometimes, however, local signs caused by mast cell degranulation may appear. Systemic signs are rare, and the results of the therapy are satisfactory in patients whose tumor resection was incomplete.
Novel therapies
The use of selective receptor tyrosine kinase inhibitors, which are involved in controlling the growth and differentiation of mast cells, has been the subject of intensive research in recent years. Toceranib (Palladia) is authorized for the treatment of non-resectable, recurrent grade II and III skin tumors; a mutation in the c-kit proto-oncogene is not a requirement for its use.
Drugs:
- masitinib (Masivet): safe and effective in delaying the progression of non-resectable or recurrent mast cell tumors of intermediate and low grade (in the absence of metastases to the lymph nodes and distant sites); in dogs with non-resectable tumors of intermediate and high grade, this drug significantly prolonged survival,
- imatinib (Gleevec),
- toceranib (Palladia).
Relieving the signs of paraneoplastic syndrome
Additional systemic signs fairly often appear in the course of MCT. We see them especially in animals with mastocytosis or with massive, aggressive mast cell tumors. In these patients, supportive drugs that ease the course of the disease are recommended.
These include:
- H2 receptor antagonists, to prevent gastrointestinal ulcers and to treat existing ones: * cimetidine (10 mg/kg twice a day), * ranitidine (0.5–2 mg/kg 2 or 3 times a day), * famotidine (0.5–1 mg/kg 1 or 2 times a day).
- Proton pump inhibitors, which inhibit the production of gastric acid by the parietal cells of the stomach: * omeprazole (0.5–1 mg/kg once a day).
- In dogs showing signs of ulceration and mucosal bleeding, sucralfate (0.5–1 g 3 times a day) is beneficial. It reacts with stomach acid to form a thick, sticky, paste-like substance that binds to the surface of the ulcers. In this way, it protects them from being broken down by digestive enzymes.
In cats with well-differentiated mast cell tumors, the first and main treatment method is surgery. Postoperative recurrence or spread of the cancer is found in 0–24% of cases, more often with poorly differentiated MCT. In the histiocytic type in young cats with multiple tumors (confirmed by histopathology), surgery is also recommended.
Many vets, however, leave such lesions "for observation", because many of them regress spontaneously at various times.
Ongoing care after mastocytoma treatment
Care of the patient at home is a very important factor. It is extremely important throughout the diagnostic and treatment process, during recovery, and then for the rest of your pet's life. You should watch and monitor the patient's skin closely, regularly look at and feel the site where the tumor was removed, and have follow-up tests done. Animals that have already developed one mast cell tumor may tend to develop more.
Cases of pets with mastocytoma
Finally, I would like to describe a few cases of G2 mastocytoma that show how different a clinical course and how different a prognosis this insidious and dangerous cancer can bring.
Mastocytoma in a dog: case 1
West Highland White Terrier, about 9 years old. A small lesion on the skin of the hind limb at the level of the hock. The right course of action: the owner went to the vet, and the tumor was removed. Unfortunately, because of its location, it could not be removed with clean surgical margins… The dog comes to us regularly for chemotherapy. He feels well and tolerates the chemo quite well. A few days ago, I had the pleasure of giving him his last dose of the chemotherapy drug.
His test results are, well, the best since he first came to our clinic. Now all that remains is to monitor his skin, do follow-up blood tests and… enjoy life. This dog and his owner were very lucky.
Mastocytoma in a dog: case 2
An older female terrier, often mistaken for a Miniature Schnauzer.
A huge, fist-sized tumor in the shoulder blade area. The patient came in with systemic signs:
- vomiting,
- loss of appetite,
- diarrhea.
The little dog patiently endured chemotherapy, as if she knew it was helping her… It was wonderful to watch the tumor shrink quickly and the skin over it become more and more "saggy." Unfortunately, during therapy I diagnosed her with pancreatitis. That nasty thing threw our treatment plan into unimaginable disarray. Certain drugs could no longer be given, and chemotherapy had to be used with care.
Together with the owner, we tried to save the pancreas, even resorting to plasma transfusions. It did not work… When we saw that the therapy was not working and the girl was simply suffering, the owner agreed to euthanasia. I was very sad: the cancer had responded beautifully, and there had been a light at the end of the tunnel. However, it is often not the tumor that directly causes the patient's death, but complications like these…
Mastocytoma in a dog: case 3
A lovely black Labrador sent for a consultation from a distant clinic: an extensive tumor in the groin area. It had been examined histopathologically before, and an abscess was diagnosed. Despite antibiotic treatment, the "abscess" showed no sign of going away.
At first glance, the lesion suggested mastocytoma:
it was huge, red and shiny like Christmas tree ornaments, with streak-like skin eruptions along its course. Surgery was performed, and the lesion was sent for histopathology. A few days later, we were told that the dog was feeling unwell, vomiting and had bloody diarrhea.
I insisted it was mastocytoma, so I recommended adding the following to the existing treatment:
- Ranigast (ranitidine),
- Claritin (loratadine),
- omeprazole.
However, the attending vet did not take the suggestion on board… Two days later came sad news from the owner: the patient had died. A few days later, the lab result arrived: grade 2 mastocytoma… I am writing about this to draw your attention to how important it is to choose a good laboratory to assess lesions of this kind. Samples are often sent to random laboratories with no experience in assessing oncology cases. The result is the wrong course of action, which only needlessly delays the start of appropriate treatment.
If you want to learn more about diet for animals with cancer, I encourage you to read the article "How to feed a dog or cat with cancer?" Have you noticed lumps on your pet and are wondering whether it might be mastocytoma? Do you have questions about the treatment of this cancer? Leave a comment below the article now, and I will try to clear up your doubts.
FAQ
Does sex matter?
No sex-related predisposition has been found in dogs. However, statistical analyses of a group of patients with mastocytoma provided interesting data: neutering or spaying was found to be associated with an increased risk of MCT in both sexes. In neutered males, this risk is slightly higher than in intact males, but in spayed females it was as much as 4 times higher than in intact females. In cats, mastocytoma may occur more often in males than in females.
How many tumors are there usually?
In many dogs, these cancers occur as a solitary form (single tumors), but in 6% of cases there may be multiple tumors. In cats, mast cell tumors occur in 2 forms:
- as single, less often multiple, skin tumors (which in some cases may metastasize to the regional lymph nodes or internal organs),
- as mastocytomas originating in internal organs (visceral mastocytoma) such as the spleen, liver and lymph nodes, without skin involvement.
Tumors in young cats can be very numerous. They appear at the same time or one after another at varying intervals.
Which dogs are most at risk of mastocytoma?
Mastocytoma can occur in dogs of any age, from 4 months to 18 years, but it most often affects senior dogs, that is, dogs 8–9 years old.
What is given during chemotherapy?
During chemotherapy, drugs such as vinblastine and lomustine, vinorelbine and paclitaxel are given.